HDAC7 and glioblastoma: Analysis of genomic data from 154 patients with glioblastoma multiforme has determined a strong correlation between HDAC7 expression and patient outcomes: Subgroup of patients with overexpressed HDAC7 has particularly poor clinical outcomes [19].